Source: VC News Daily

RA Capital: Aerovate Therapeutics Inks $72.6M Series A

BOSTON, MA, Aerovate Therapeutics has closed on $72.6 million in Series A funding.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Peter Kolchinsky's photo - Managing Partner of RA Capital

Managing Partner

Peter Kolchinsky

CEO Approval Rating

68/100

RA Capital Management is a venture capital firm that invests in healthcare and life-sciences companies. Read more